Skip To Main Content
Sanobar Syed on Muck Rack

Sanobar Syed

As seen in: Financial Express, Pharmaceutical Online, Bioprocess Online, Express Pharma, MedTech Intelligence, Outsourced Pharma, Omnia Health, Cell & Gene, Biosimilar Development, Pharma Focus Asia
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sanobar

Contact Sanobar, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Pharmaceutical Business Strategy and Forecasting Creating insights from market research

|
By Sanobar Syed
| Indibloghub
Author: Sanobar Syed, Associate Director, Beigene In the increasing uncertainties and volatile market, pharmaceutical companies have to rethink their approach to forecasting in oncology. When projections are misaligned, pharma companies will have to answer shareholders. But when forecasters get it right, manufacturers can optimise resources to fit the opportunity and produce plans that deliver innovative medicines to patients who need them.
Open in Who Shared Issue with article?

Overcoming Forecasting Challenges in Cell and Gene Therapies

|
By Sanobar Syed
| MedTech Intelligence
Forecasting is a vital activity that supports a range of key business decisions across a broad range of stakeholders in pharma and medtech. And it is not just about crunching numbers; it’s about interpreting data effectively and using it to make informed decisions promptly.
Open in Who Shared Issue with article?

Building blocks for a future-ready healthcare

|
By Sanobar Syed
| Omnia Health Verified
The year 2023 has just paved the way for a new future. We have almost fully recovered from the aftermath of the unprecedented pandemic and in the past few years, pharma companies have realised the importance of data. To quote British mathematician and entrepreneur Clive Humby, data is indeed the ‘new oil for pharma companies’ and much more than that.
Open in Who Shared Issue with article?
See all 26 articles